Suppr超能文献

口腔白斑病。一项为期五年的随访研究。

Oral Leukoplakia. A Five-Year Follow-Up Study.

作者信息

Serban Andrei-Eduard, Nicolae Carmen, Parlatescu Ioanina, Tovaru Serban

机构信息

Doctoral School of "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Department of Oral Pathology, Faculty of Dentistry, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Maedica (Bucur). 2023 Dec;18(4):645-650. doi: 10.26574/maedica.2023.18.4.645.

Abstract

Oral leukoplakia (OLK) is the most studied oral potentially malignant disorders in the scientific literature. Its malignant transformation (MT) rate varies between 1.1% and 40.8%, depending on the type of study and population group studied. There is no universal agreement to treat or manage these lesions, so it is up to each clinician's experience and expertise in how he/she manages these patients. The aim of this retrospective study was to assess the clinical aspects and pattern of evolution of OLK in 30 patients five years or more after the initial diagnosis. We selected 30 OLK patients from our database. Demographic, clinical and evolutive data was retrieved from the medical files. The following variables were analysed: age and sex, smoking habits, clinical features (form, dimension, site of the lesion), result of mycological examination, treatment and outcomes of the lesions over a follow-up of more than five years. For a follow-up of 119.63 months, we detected a value of 0.2% MT rate per year. Outcomes varied from the complete disappearance of the lesion to recurrence and malignant transformation with a variety of treatment methods applied. Despite the low MT rate for a long follow-up, it is hard to say which treatment method is the best, due to the heterogeneity of the clinical aspects of the lesions and because there is no standardised test method, either genetic testing or immunohistochemical testing. We recommend a varied approach, suitable for each patient's needs and medical context, always when possible histopathological confirmation for grading epithelial dysplasia, which remains the most reliable method of checking the process of malignant transformation.

摘要

口腔白斑(OLK)是科学文献中研究最多的口腔潜在恶性疾病。其恶变率在1.1%至40.8%之间,具体取决于研究类型和所研究的人群组。对于这些病变的治疗或处理尚无普遍共识,因此如何管理这些患者取决于每位临床医生的经验和专业知识。这项回顾性研究的目的是评估30例患者在初次诊断五年或更长时间后的口腔白斑的临床特征和演变模式。我们从数据库中选取了30例口腔白斑患者。从病历中检索人口统计学、临床和演变数据。分析了以下变量:年龄和性别、吸烟习惯、临床特征(形态、尺寸、病变部位)、真菌学检查结果、治疗方法以及超过五年随访期内病变的转归。在119.63个月的随访期内,我们检测到每年的恶变率为0.2%。采用了多种治疗方法,病变转归从完全消失到复发和恶变不等。尽管长期随访的恶变率较低,但由于病变临床特征的异质性以及缺乏标准化的检测方法(无论是基因检测还是免疫组织化学检测),很难说哪种治疗方法是最佳的。我们建议采用因人而异的方法,根据每位患者的需求和医疗背景进行调整,尽可能始终进行组织病理学确认以评估上皮发育异常的分级,这仍然是检查恶变过程最可靠的方法。

相似文献

1
Oral Leukoplakia. A Five-Year Follow-Up Study.
Maedica (Bucur). 2023 Dec;18(4):645-650. doi: 10.26574/maedica.2023.18.4.645.
3
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
4
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Interventions for treating oral leukoplakia to prevent oral cancer.
Cochrane Database Syst Rev. 2016 Jul 29;7(7):CD001829. doi: 10.1002/14651858.CD001829.pub4.
9
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Interventions for Old World cutaneous leishmaniasis.
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.

本文引用的文献

1
The global prevalence of oral leukoplakia: a systematic review and meta-analysis from 1996 to 2022.
BMC Oral Health. 2023 Sep 6;23(1):645. doi: 10.1186/s12903-023-03342-y.
2
Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Nov;134(5):573-587. doi: 10.1016/j.oooo.2022.07.006. Epub 2022 Jul 21.
3
Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.
Front Pharmacol. 2022 Apr 20;13:825266. doi: 10.3389/fphar.2022.825266. eCollection 2022.
4
Treatment of oral leukoplakia with CO2 laser (10,600 nm): analysis of 37 cases.
Braz Oral Res. 2022 Jan 14;36:e014. doi: 10.1590/1807-3107bor-2022.vol36.0014. eCollection 2022.
5
Difficulties in the Prognostic Study of Oral Leukoplakia: Standardisation Proposal of Follow-Up Parameters.
Front Oral Health. 2021 Feb 5;2:614045. doi: 10.3389/froh.2021.614045. eCollection 2021.
6
Oral leukoplakia: A clinicopathological study and malignant transformation.
Oral Dis. 2023 May;29(4):1454-1463. doi: 10.1111/odi.14123. Epub 2022 Jan 20.
7
Associations between clinical and histopathological characteristics in oral leukoplakia.
Oral Dis. 2023 Mar;29(2):696-706. doi: 10.1111/odi.14038. Epub 2021 Oct 14.
8
Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
Oral Dis. 2021 Nov;27(8):1881-1895. doi: 10.1111/odi.13810. Epub 2021 Apr 1.
10
Oral leukoplakia, a clinical-histopathological study in 412 patients.
J Clin Exp Dent. 2020 Jun 1;12(6):e540-e546. doi: 10.4317/jced.57091. eCollection 2020 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验